This is truly exciting news, we haven't seen this level of trading volume in quite some time. It's important to remember that the price reached an all-time high in 2021 during the initial patient trials, highlighting the strong potential and growing interest in IBX.
In my opinion, IBX has made remarkable progress and is now positioned for significant future growth.
Ann: Imagion Receive Positive FDA Feedback for HER2 Phase 2 Trial, page-8
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.8¢ |
Change
0.002(12.5%) |
Mkt cap ! $3.624M | |||
| Open | High | Low | Value | Volume |
| 1.7¢ | 1.8¢ | 1.6¢ | $83.00K | 4.745M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2688199 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 350895 | 2 |
View Market Depth
| Last trade - 16.10pm 21/07/2025 (20 minute delay) ? |
| IBX (ASX) Chart |